|

ALIGNMENT HEALTHCARE INC (ALHC)

US01625V1044 - Common Stock

7.56  -0.02 (-0.2%)

After market: 7.56 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates.

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
959.2M
26.71%
1.168B
21.75%
1.434B
22.81%
1.818B
26.76%
EBITDA
YoY % growth
10.16M
178.64%
-162.07M
-1,695.18%
-111.11M
31.44%
-27.415M
75.33%
N/AN/A
EBIT
YoY % growth
-5.3M
82.03%
-178.1M
-3,260.38%
-128.6M
27.79%
-87.769M
31.75%
N/AN/A
Operating Margin
-0.55%-15.25%-8.97%-4.83%N/AN/A
EPS
YoY % growth
N/A-1.13N/A-0.77

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.22
28.55%
Revenue
Q2Q % growth
451.07M
24.67%
EBITDA
Q2Q % growth
-14.699M
EBIT
Q2Q % growth
-29.87M
42.67%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSuprise
Q3 2023
Q2Q % growth
-0.18
18.18%
-0.190.013.30%
Q2 2023
Q2Q % growth
-0.15
-150.00%
-0.220.0732.72%
Q1 2023
Q2Q % growth
-0.20
13.04%
-0.260.0622.89%
Q4 2022
Q2Q % growth
-0.31
-14.81%
-0.30-0.01-2.28%
Q3 2022
Q2Q % growth
-0.22
15.38%
-0.250.0312.22%
Q2 2022
Q2Q % growth
-0.06
76.00%
-0.260.2077.19%
Q1 2022
Q2Q % growth
-0.23
34.29%
-0.250.028.34%
Q4 2021
Q2Q % growth
-0.27 -0.300.0311.40%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSuprise
Q3 2023
Q2Q % growth
456.7M
26.76%
453.14M3.56M0.79%
Q2 2023
Q2Q % growth
462.4M
26.17%
447.81M14.59M3.26%
Q1 2023
Q2Q % growth
439.2M
27.12%
440M-800K-0.18%
Q4 2022
Q2Q % growth
361.8M
21.29%
347.94M13.86M3.98%
Q3 2022
Q2Q % growth
360.3M
22.76%
340.07M20.23M5.95%
Q2 2022
Q2Q % growth
366.5M
18.61%
344.73M21.77M6.32%
Q1 2022
Q2Q % growth
345.5M
29.35%
339.13M6.37M1.88%
Q4 2021
Q2Q % growth
298.3M
22.61%
274.97M23.33M8.48%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-3.4% 4.4% 0% 3.12%
Revenue1.32% 2.1% 0% 1.22%